Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
and suppressed tumor growth in vivo with a concomitant reduction in vessel formation
Smiles: [O-][N+](=O)C1=CC(Cl)=CC=C1S(=O)(=O)C1C=CC=CC=1
InChiKey: VUNOFAIHSALQQH-UHFFFAOYSA-N
also known as PROTAC cIAP1 degrader-4
MLN8237 is currently in Phase II study for treatment of patients with ovarian
Exatecan Mesylate - CAS# 169869-90-3 0271 and suppressed tumor growth inExatecan Mesylate, CAS No. 169869 90 3, also known as DX 8951, is semisynthetic, water soluble camptothecin derivative with antineoplastic activity. Exatecan mesylate inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA and inhibiting religation of DNA breaks, thereby inhibiting DNA replication and triggering apoptotic cell death. This agent does not require enzymatic activation and exhibits greater
US$ 88.00
US$ 1768.50
US$ 1629.50
US$ 30.00